Does successful viral eradication translate into beneficial long-term clinical outcome of patients with advanced liver disease due to hepatitis C after DAA therapy?

  • K Kozbial
  • , S Moser
  • , R Schwarzer
  • , R Al Zoairy
  • , RE Stauber
  • , H Laferl
  • , A Maieron
  • , HM Zoller
  • , S Beinhardt
  • , A Staattermayer
  • , R Stern
  • , PE Steindl-Munda
  • , Michael Strasser
  • , M Peck-Radosavljevic
  • , I Graziadei
  • , MH Trauner
  • , H Hofer
  • , P Ferenci

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageEnglish
Pages (from-to)447A-447A
JournalHEPATOLOGY
Volume63
Issue number1 SUPP
Publication statusPublished - 2016
Event67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA
Duration: 11 Nov 201615 Nov 2016

Cite this